BioSpace News Archive

From coast to coast to coast, Canadians have been making extraordinary sacrifices to keep themselves, their families, and their communities safe from COVID-19.

Sincera Reproductive Medicine, formerly known as Abington Reproductive Medicine, announced that it has taken action after becoming aware of potential unauthorized access to certain patient information.

Scientific Industries, Inc., a life sciences tool provider, and a developer of optical sensors for non-invasive, real-time monitoring of cell culture systems through its subsidiary Scientific Bioprocessing, Inc., reported financial results for the third quarter of fiscal 2021 ended March 31, 2021.

The National Institute of Allergy and Infectious Diseases will fund the continued clinical development of product candidate SPR206

FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to present data by year-end

Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, reported financial results and a business update for the three months ended March 31, 2021.

REDUCE-IT® patients experienced substantial cardiovascular (CV) risk reduction with icosapent ethyl regardless of the presence or degree of dyslipidemia, as defined by various high TG plus low HDL-C levels

Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, announced that the company will hold a conference call and live webcast on Thursday, May 27, 2021 at 4:30 p.m. Eastern Time to review its first quarter 2021 financial results and provide a business update.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced financial results for the three months ended March 31, 2021 and provided a business update.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it is postponing its previously announced investor conference call scheduled to be held on Monday, May 17, 2021, at 2 p.m. Pacific Time.